The SEC lists BioCardia, Inc. under CIK 0000925741, in biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
Footnote F1 (price, shares): This transaction was executed in multiple trades ranging from $1.02 to $1.05 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of… Full note on SEC EDGAR
Footnote F1 (price, shares): This transaction was executed in multiple trades ranging from $1.04 to $1.08 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of… Full note on SEC EDGAR
Footnote F1 (price, shares): This transaction was executed in multiple trades ranging from $1.09 to $1.10 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of… Full note on SEC EDGAR
Footnote F1 (price, shares): This transaction was executed in multiple trades ranging from $0.92 to $0.97 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of… Full note on SEC EDGAR
Footnote F1 (price, shares): This transaction was executed in multiple trades ranging from $0.89 to $0.95 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of… Full note on SEC EDGAR
Footnote F1 (price, shares): This transaction was executed in multiple trades ranging from $0.77 to $0.80 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of… Full note on SEC EDGAR
Footnote F1 (price, shares): This transaction was executed in multiple trades ranging from $0.86 to $0.89 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of… Full note on SEC EDGAR
Footnote F2 (price, shares): This transaction was executed in multiple trades ranging from $0.86 to $0.89 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of… Full note on SEC EDGAR
Footnote F1 (price, shares): This transaction was executed in multiple trades ranging from $0.92 to $1.05 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of… Full note on SEC EDGAR
Footnote F1 (price, shares): The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement on July 2, 2026, of the RSUs vested on June 29, 2026 and does not represent a sale by the… Full note on SEC EDGAR
Footnote F1 (price, shares): The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement on July 2, 2026, of the RSUs vested on June 29, 2026 and does not represent a sale by the… Full note on SEC EDGAR
Footnote F1 (price, shares): The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement on July 2, 2026, of the RSUs vested on June 29, 2026 and does not represent a sale by the… Full note on SEC EDGAR
Footnote F1 (price, shares): The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on June 29, 2026.
Footnote F1 (price, shares): The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on June 29, 2026.
Footnote F1 (price, shares): The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on June 29, 2026.
Footnote F1 (price, shares): This transaction was executed in multiple trades ranging from $0.90 to $0.97 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of… Full note on SEC EDGAR
Footnote F2 (price, shares): This transaction was executed in multiple trades ranging from $1.00 to $1.01 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of… Full note on SEC EDGAR
Footnote F1 (price, shares): This transaction was executed in multiple trades ranging from $0.84 to $0.89 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of… Full note on SEC EDGAR
Footnote F2 (price, shares): This transaction was executed in multiple trades ranging from $0.98 to $0.96 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of… Full note on SEC EDGAR
Footnote F1 (price, shares): This transaction was executed in multiple trades ranging from $0.9506 to $0.9508 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security… Full note on SEC EDGAR
Footnote F2 (price, shares): This transaction was executed in multiple trades ranging from $0.91 to $0.95 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of… Full note on SEC EDGAR
Footnote F1 (price, shares): This transaction was executed in multiple trades ranging from $0.89 to $1.02 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of… Full note on SEC EDGAR
Footnote F1 (price, shares): This transaction was executed in multiple trades ranging from $1.01 to $1.03 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of… Full note on SEC EDGAR
Footnote F1 (price, shares): This transaction was executed in multiple trades ranging from $1.22 to $1.27 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of… Full note on SEC EDGAR
Footnote F2 (price, shares): This transaction was executed in multiple trades ranging from $1.21 to $1.24 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of… Full note on SEC EDGAR
Footnote F1 (price, shares): This transaction was executed in multiple trades ranging from $1.24 to $1.26 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of… Full note on SEC EDGAR
Footnote F2 (price, shares): This transaction was executed in multiple trades ranging from $1.19 to $1.25 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of… Full note on SEC EDGAR
BioCardia, Inc. (BCDA) had 7 insider filings in the last 90 days, with the most recent on 2026-09-30. The full record for BCDA runs to 58 Form 4 filings, the earliest from 2024-10-16. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BCDA stock?
7 insider purchases of BCDA were filed in the last 90 days, totaling $15K.
How many insiders are selling BCDA stock?
No insider sales of BCDA were filed in the last 90 days. 1 sale is on record for this company.
Where can I see BCDA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BCDA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.